A Pharmaceuticals and Healthcare (Contract Research & Manufacturing Services (CRAMS)) entity from India is looking to sellout.
Posted By - Investment Banker
Posted date - 29/08/2020
BUSINESS BRIEF
EU GMP approved pharmaceutical contract research and manufacturing facility located in Himachal Pradesh having a manufacturing capacity of 300 million plus doses in a month. Varied and customizable manufacturing capabilities. Also having Export license and international approvals in place.
Proposal
Industry
Pharmaceuticals
Sub Industry
Contract Research & Manufacturing Services (CRAMS)
Deal Size
INR 112.5 - 120 Cr
Motives For Sellout
Strategic Realignment
Entity is open for Investor Keen on Special Situations/distress assets funding
Management is open to continue with the business for handholding the new investor/buyers
Business Operation Information
Industry
Pharmaceuticals
Sub-Industry
Contract Research & Manufacturing Services (CRAMS)
Division
Division`s Buyers/Customers
Financial Information |
2017 (in Cr) | 2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) |
|---|---|---|---|---|
Sales |
N.D | N.D | INR 10 Cr | INR 12 Cr |
EBITDA |
N.D | N.D | N.D | N.D |
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
N.D | N.D | N.D | N.D |
